Cortes-Funes H - Search Results

1

Phase I pharmacokinetic/pharmacodynamic study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor tyrosine kinase, in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in first-line treatment of patients with metastatic colorectal cancer.

Folprecht G, Tabernero J, Köhne CH, Zacharchuk C, Paz-Ares L, Rojo F, Quinn S, Casado E, Salazar R, Abbas R, Lejeune C, Marimón I, Andreu J, Ubbelohde U, Cortes-Funes H, Baselga J. Folprecht G, et al. Clin Cancer Res. 2008 Jan 1;14(1):215-23. doi: 10.1158/1078-0432.CCR-07-1053. Clin Cancer Res. 2008. PMID: 18172273 Clinical Trial.

2

The management of non-seminomatous germ cell tumours (GCT).

Paz-Ares L, Lianes P, Cortes-Funes H. Paz-Ares L, et al. Ann Oncol. 1994 May;5(5):457-62. doi: 10.1093/oxfordjournals.annonc.a058880. Ann Oncol. 1994. PMID: 7521207 Free article. No abstract available.

3

Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy.

Hidalgo M, Paz-Ares L, Rivera F, Lianes P, Huidobro G, Ruiz A, López-Brea M, Sanz-Ortiz J, López López J, Cortés-Funes H, Tabernero JM. Hidalgo M, et al. Ann Oncol. 1997 Jun;8(6):555-9. doi: 10.1023/a:1008225129682. Ann Oncol. 1997. PMID: 9261524 Free article. Clinical Trial.

4

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.

García-Carbonero R, Hidalgo M, Paz-Ares L, Calzas J, Gómez H, Guerra JA, Hitt R, Hornedo J, Colomer R, Cortés-Funes H. García-Carbonero R, et al. J Clin Oncol. 1997 Oct;15(10):3178-84. doi: 10.1200/JCO.1997.15.10.3178. J Clin Oncol. 1997. PMID: 9336353

5

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

Hitt R, Paz-Ares L, Hidalgo M, Colomer R, Brandariz A, Peña M, Alvarez-Vicent J, Hornedo J, Cortés-Funes H. Hitt R, et al. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-20-S19-24. Semin Oncol. 1997. PMID: 9427260 Clinical Trial.

6

A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer.

Castellano D, Lianes P, Paz-Ares L, Hidalgo M, Guerra JA, Gómez-Martín C, Gómez H, Calzas J, Cortés-Funes H. Castellano D, et al. Ann Oncol. 1998 Apr;9(4):457-9. doi: 10.1023/a:1008276507236. Ann Oncol. 1998. PMID: 9636840 Free article. Clinical Trial.

7

Favorable prognosis after late relapse of Hodgkin's disease.

Garcia-Carbonero R, Paz-Ares L, Arcediano A, Lahuerta J, Bartolome A, Cortes-Funes H. Garcia-Carbonero R, et al. Cancer. 1998 Aug 1;83(3):560-5. Cancer. 1998. PMID: 9690550

8

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.

Hidalgo M, Castellano D, Paz-Ares L, Gravalos C, Diaz-Puente M, Hitt R, Alonso S, Cortes-Funes H. Hidalgo M, et al. J Clin Oncol. 1999 Feb;17(2):585-92. doi: 10.1200/JCO.1999.17.2.585. J Clin Oncol. 1999. PMID: 10080603 Clinical Trial.

9

Tumor markers at the time of recurrence in patients with germ cell tumors.

Trigo JM, Tabernero JM, Paz-Ares L, García-Llano JL, Mora J, Lianes P, Esteban E, Salazar R, López-López JJ, Cortés-Funes H. Trigo JM, et al. Cancer. 2000 Jan 1;88(1):162-8. doi: 10.1002/(sici)1097-0142(20000101)88:1<162::aid-cncr22>3.0.co;2-v. Cancer. 2000. PMID: 10618619

10

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.

Bellmunt J, Guillem V, Paz-Ares L, González-Larriba JL, Carles J, Albanell J, Tabernero JM, Cortés-Funes H, Baselga J. Bellmunt J, et al. Eur J Cancer. 2000 Jul;36 Suppl 2:17-25. doi: 10.1016/s0959-8049(00)00081-2. Eur J Cancer. 2000. PMID: 10908844 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters